1. Home
  2. LOOP vs SCLX Comparison

LOOP vs SCLX Comparison

Compare LOOP & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$0.48

Market Cap

39.7M

Sector

Industrials

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$5.35

Market Cap

35.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
SCLX
Founded
2010
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.7M
35.2M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
LOOP
SCLX
Price
$0.48
$5.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
235.8K
32.7K
Earning Date
05-28-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
27.27
N/A
EPS
N/A
N/A
Revenue
$10,889,000.00
$30,253,000.00
Revenue This Year
N/A
$122.52
Revenue Next Year
$174.82
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
7016.99
N/A
52 Week Low
$0.41
$4.20
52 Week High
$1.99
$30.90

Technical Indicators

Market Signals
Indicator
LOOP
SCLX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
LOOP
SCLX

About LOOP Loop Industries Inc.

Loop Industries Inc is a technology company whose mission is to accelerate the world's shift toward sustainable PET plastic and polyester fiber and away from dependence on fossil fuels. Loop Industries owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber, including plastic bottles, packaging, and textiles such as carpets and clothing, into its base building block monomers, DMT and MEG.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: